Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 24.70
-0.50 (-1.98%)
At close: Jun 22, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 140.85 million as of June 22, 2026. Its market cap has increased by 23.58% in one year.
Market Cap
140.85M
Enterprise Value
286.20M
Revenue
275.31K
Ranking
n/a
PE Ratio
n/a
Stock Price
24.70
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 140.85M, a decrease of -41.43%. That is a compound annual growth rate of -11.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 140.85M | -1.13% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.09B |
| Idorsia | 1.45B |
| Basilea Pharmaceutica AG | 635.91M |
| Newron Pharmaceuticals | 253.83M |
| Santhera Pharmaceuticals Holding AG | 236.47M |
| BioVersys AG | 156.32M |
| Molecular Partners AG | 115.91M |
| MindMaze Therapeutics Holding | 32.89M |